Epstein Secrets

Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug compani

nt on the upcoming election, with discussion on voter turnout and how national security will play a 'key role' in the election, with Democratic Rep. Karen Bass, Voto Latino CEO and President Maria Teresa Kumar, and former National Security Advisor Lt. Gen. (Ret.) Henry McMaster; 3:30 PM • Armenian foreign

al-trials-pfizer- cincinnati/3709031001/> (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug companie

nt on the upcoming election, with discussion on voter turnout and how national security will play a `key role' in the election, with Democratic Rep. Karen Bass, Voto Latino CEO and President Maria Teresa Kumar, and former National Security Advisor Lt. Gen. (Ret.) Henry McMaster; 3:30 PM * Armenian foreign

do more activities socially. I do think it's going to make a big difference in opening our society back up." The AP (5/25, Neergaard) reports that Pfizer and Moderna "have begun testing in even younger children, from age 11 down to 6- month-old babies." Reuters (5/25, Steenhuysen) reports that FDA reg

re needs to be bipartisan compromise. We need 60 votes which is why we're encouraged to see" Sens. Cory Booker (D-NJ) and Tim Scott (R-SC) and Rep. Karen Bass (D-CA) "and others negotiating seriously and in good faith to see if we could get a meaningful reform bill out of the Senate that will move the bal

Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug compani

nt on the upcoming election, with discussion on voter turnout and how national security will play a 'key role' in the election, with Democratic Rep. Karen Bass, Voto Latino CEO and President Maria Teresa Kumar, and former National Security Advisor Lt. Gen. (Ret.) Henry McMaster; 3:30 PM • Armenian foreign

s (4/25, Robbins, 20.6M) reports that according to the CDC, "more than five million people, or nearly 8 percent of those who got a first shot of the Pfizer or Moderna vaccines, have missed their second doses." The Times adds that as the US tries to encourage many people to receive a first dose, many he

law enforcement community in a position that they've got to second-guess themselves when they're trying to make sure people are staying safe." Rep. Karen Bass (D-CA), on ABC's This WeekVI (4/25, 2.44M), said, "We've been having information conversations with one of the caucuses in the House called the Prob

o do more activities socially. I do think it's going to make a big difference in opening our society back up." The AP (5/25, Neergaard) reports that Pfizer and Moderna "have begun testing in even younger children, from age 11 down to 6-month-old babies." Reuters (5/25, Steenhuysen) reports that FDA reg

re needs to be bipartisan compromise. We need 60 votes which is why we're encouraged to see" Sens. Cory Booker (D-NJ) and Tim Scott (R-SC) and Rep. Karen Bass (D-CA) "and others negotiating seriously and in good faith to see if we could get a meaningful reform bill out of the Senate that will move the bal